Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorMatur, Zeliha
dc.contributor.authorAtmaca, M.M.
dc.contributor.authorDurmus, H.
dc.contributor.authorParman, Y.
dc.date.accessioned2015-01-23T13:49:09Z
dc.date.available2015-01-23T13:49:09Z
dc.date.issued2014
dc.identifier.citationMatur Z, Atmaca MM, Durmus H, Parman Y. Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation. Joint Congress of European Neurology, Istanbul, Turkey, May 2014. European Journal of Neurology. 2014; 21(Suppl 1): 453en_US
dc.identifier.issn1351-5101
dc.identifier.urihttps://hdl.handle.net/11446/680en_US
dc.descriptionİstanbul Bilim Üniversitesi, Tıp Fakültesi.en_US
dc.description.abstractDomino liver transplantation (DLT) increase the number of grafts available to treat patients with liver disease. But, this procedure has a risk of transmission of systemic transthyretin (TTR) amyloidosis. A 69-year-old FAP male patient whose complaints started 8 years after DLT was evaluated because of numbness and burning sensation of feet and hands, walking difficulty, dizziness, diarrhea, dry mouth, urinary retention.en_US
dc.description.urihttp://onlinelibrary.wiley.com/doi/10.1111/ene.12497/epdfen_US
dc.language.isoengen_US
dc.publisherWiley-Blackwellen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantationen_US
dc.typeconferenceObjecten_US
dc.relation.journalEuropean Journal of Neurologyen_US
dc.departmentDBÜ, Tıp Fakültesien_US
dc.identifier.issueSuppl. 1
dc.identifier.volume21
dc.identifier.startpage543
dc.identifier.endpage543
dc.contributor.authorIDTR118245en_US
dc.contributor.authorIDTR125998en_US
dc.contributor.authorIDTR126261en_US
dc.relation.publicationcategoryBelirsizen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster